Oxygen for the delivery room respiratory support of moderate‐to‐late preterm infants. An international survey of clinical practice from 21 countries. (12th September 2021)

• Record Type: Journal Article
• Authors: Sotiropoulos, James X.; Kapadia, Vishal; Vento, Maximo; Rabi, Yacov; Saugstad, Ola D.; Kumar, R. Kishore; Schmölzer, Georg M.; Zhang, Huyan; Yuan, Yuan; Lim, Gina; Kusuda, Satoshi; Arimitsu, Takeshi; Nguyen, Tinh Thu; Kitsommart, Ratchada; Yeo, Kee Thai; Oei, Ju Lee
• Is Part Of: Acta pædiatrica. Volume 110:Number 12(2021)
• Page Start: 3261
• Page End: 3268
• Publication Date: 2021-09-12
• Subjects: delivery room practice -- moderate‐late preterm infant -- neonatal resuscitation -- oxygen concentration -- oxygen saturation; Pediatrics -- Periodicals; Pediatrics; 618.92
• DOI: 10.1111/apa.16091
• Languages: English
• ISSNs: 0803-5253

Abstract

Abstract: Aim: The aim of this study was to determine clinician opinion regarding oxygen management in moderate‐late preterm resuscitation. Methods: An anonymous online questionnaire was distributed through email/social messaging platforms to neonatologists in 21 countries (October 2020‐March 2021) via REDCap. Results: Of the 695 respondents, 69% had access to oxygen blenders and 90% had pulse oximeters. Respondents from high‐income countries were more likely to have oxygen blenders than those from middle‐income countries (72% vs. 66%). Most initiated respiratory support with FiO2 0.21 (43%) or 0.3 (36%) but only 45% titrated FiO2 to target SpO2 . Most (89%) considered heart rate as a more important indicator of response than SpO2 . Almost all (96%) supported the need for well‐designed trials to examine oxygenation in moderate‐late preterm resuscitation. Conclusion: Most clinicians resuscitated moderate‐late preterm infants with lower initial FiO2 but some cannot/will not target SpO2 or titrate FiO2 . Most consider heart rate as a more important indicator of infant response than SpO2 .Large and robust clinical trials examining oxygen use for moderate‐late preterm resuscitation, including long‐term neurodevelopmental outcomes, are supported amongst clinicians.